Purdue prototypes wearable AI epinephrine injector, seeks industry partners for commercialization

Purdue University described a research prototype that integrates advanced physiological sensors, encrypted communications, an edge-AI decision system and automated drug-delivery hardware (microfluidic and spring-based injection systems). The team reports work on sensor optimization, signal conditioning, power-efficient components, mechanical injection elements and real-world simulation testing to assess functionality, reliability and safety.

Next development steps reported include validating system reliability, documenting false-positive and false-negative rates, understanding regulatory and clinical validation pathways, and integrating sensors, signal-conditioning electronics, edge-AI, power management and the injection mechanism into more integrated prototypes. Purdue Innovates (managed by the Purdue Research Foundation) has been notified and a nonprovisional patent application was filed; industry partners were directed to contact Parag Vasekar (psvasekar@prf.org). Media contact listed: Steve Martin (sgmartin@prf.org).

Report a correction · Editorial standards · Our source directory

BusinessIndy examines this development and its implications for Indiana businesses and communities using the linked sources.